Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement

NCT06073938 · clinicaltrials.gov ↗

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors or Lymphomas

Interventions

DRUG: NHWD-870

Sponsor

Hunan Province Tumor Hospital